GlobeNewswire 2021-10-06 Recro Reports Inducement Grants For New Staff
GlobeNewswire 2021-09-24 Capricor Therapeutics Announces Positive Final Data From its Phase 2 HOPE-2 Trial in Patients with D...
GlobeNewswire 2021-09-08 Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire 2021-08-24 Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell ...
GlobeNewswire 2021-08-17 Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corpora...
GlobeNewswire 2021-08-10 Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-07-20 Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
GlobeNewswire 2021-06-21 Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
GlobeNewswire 2021-06-02 Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and t...
GlobeNewswire 2021-05-27 Arbor Continues to Build Therapeutic Focus with Key Scientific Leaders
GlobeNewswire 2021-05-17 Gracell Biotechnologies Reports First Quarter 2021 Unaudited Financial Results and Provides Corporat...
GlobeNewswire 2021-05-17 Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire 2021-05-13 Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-05-13 aTyr Pharma Announces First Quarter 2021 Results and Provides Corporate Update
GlobeNewswire 2021-05-03 Affinia Therapeutics Closes $110 Million Series B Financing
GlobeNewswire 2021-04-14 aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire 2021-04-01 Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
GlobeNewswire 2021-03-12 Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
GlobeNewswire 2021-03-03 Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
GlobeNewswire 2021-02-25 Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 2021-01-12 Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire 2021-01-08 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire 2020-12-23 Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire 2020-12-16 Recro Announces Executive Changes
GlobeNewswire 2020-12-07 Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors